대한약학회:학술대회논문집 (Proceedings of the PSK Conference)

대한약학회 (The Pharmaceutical Society of Korea)
권호 표지

A newly antiarrhythmic drug CW-2202 is ideal in treating atrial fibrillation

  • Eun, Jae-Soon (College of Pharmacy, Woosuk University) ;
  • Kim, Dae-Keun (Dept. of Pharmacology, Chonbuk National Unviersity Medical School) ;
  • Chae, Soo-Wan (Dept. of Pharmacology, Chonbuk National Unviersity Medical School) ;
  • Kwak, Yong-Geun (Dept. of Pharmacology, Chonbuk National Unviersity Medical School)
  • 발행 : 2002.10.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

A number of patients suffering from atrial fibrillation are increasing and many cardiologists are trying to develop the ideal antiarrhythmic drugs for atrial fibrillation. Previously, we found out that CW-2202, a furanocoumarin derivative inhibited the hKvl.5 current expressing predominantly in human atrium without affecting the HERG current expressing mainly in ventricle. (omitted)

키워드